Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Journal of the European Academy of Dermatology and Venereology : JEADV|September 24, 2016
Nail involvement as a negative prognostic factor in biological therapy for psoriasis: a retrospective studyF Bardazzi, M Lambertini, M A Chessa, et al.Scientific Reports|February 2, 2022
Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor geneE Ntemou, P Diaz Vidal, C Alexandri, et al.ESMO Open|March 20, 2021
CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysisE Agostinetto, L Vian, R Caparica, et al.Climacteric : the Journal of the International Menopause Society|January 25, 2023
Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivorsC Massarotti, G Asinaro, M G Schiaffino, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysisF Poggio, M Bruzzone, M Ceppi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 2, 2017
Oral melanoma and other pigmentations: when to biopsy?M Lambertini, A Patrizi, P A Fanti, et al.ESMO Open|June 2, 2022
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysisG Nader-Marta, D Martins-Branco, E Agostinetto, et al.ESMO Open|April 25, 2025
Extended adjuvant endocrine therapy in early breast cancer: finding the individual balanceS Lobo-Martins, L Arecco, T P Cabral, et al.Cancer Treatment Reviews|May 20, 2017
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trialsC Solinas, M Ceppi, M Lambertini, et al.Oncology and Therapy|April 3, 2023
The Future of Breast Cancer Research in the Survivorship FieldD Soldato, L Arecco, E Agostinetto, et al.Pageof 7